Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma, Transitional Cell × RXDX-106 × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Genitourinary 1 Dermatologic 1

Conditions

Melanoma 1 Hodgkin Disease 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorodeoxyglucose F18 2 fluciclovine F-18 1 atezolizumab 1 X-Rays 1 Radium-223 1 RXDX-106 1 Positron Emission Tomography Computed Tomography 1 Magnetic Resonance Spectroscopy 1 Aminophylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03454243 2019-04-25

TITAN

Hoffmann-La Roche

Phase EARLY_PHASE1 Terminated

DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡